Industrial biotech firm Evolva now has the rights to use CRISPR/Cas9 to engineer yeast and fungi that make compounds like stevia and resveratrol.
Researchers took two complementary approaches to assemble the Xenopus laevis genome — whole-genome and long-insert clone-based end sequencing.
Researchers from Pacific Biosciences and elsewhere tested their approach on Arabidopsis thaliana before applying it to wine grape and coral fungus genomes.
The company said it expects a 1 percent increase in 2016 revenues, but noted that the results were adversely affected by certain competitive pressures in Q4, among other problems.
Vanderbilt University researchers uncovered a spider toxin gene within the WO bacteriophage, which infects the parasite Wolbachia.
In Nature this week: genetic history of HIV in the US, and more.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.
A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.